Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Adelis passes the baton in Nordentic to Corus

Adelis Equity Partners Fund I (“Adelis”) divests its majority stake in Nordentic, the largest dental labs Group in the Nordics, to Corus. Corus is a leading dental labs Group in Europe, with operations in France, Spain, the Netherlands, Belgium and Portugal.Adelis invested in Nordentic in 2017, in partnership with the founders and key management of Nordentic, including the CEO, Johnny Tekin. During Adelis’ ownership, over 20 dental labs have come together as one Group, and as a pioneer in the technical development of the industry. By combining management’s deep industrial knowledge with

Salsa Technology Set to Play Major Role at CGS Brasil 2022

The conference is being held in Florianópolis and it will be the first in-person edition following the pandemic.Salsa Technology is set to play a major role at CGS Brasil 2022 which takes place between 12th - 13th September 2022. The conference is being held in Florianópolis and it will be the first in-person edition following the pandemic.  Salsa will be out in force as a large part of the team is based in the capital of Santa Catarina, which is widely recognised as the ‘Brazilian Silicon Valley’. Salsa Technology 's Lead Account Manager, Camila Alves,

P CAPITAL PARTNERS IV B ISSUES NEW DEBENTURES

PRESS RELEASE Stockholm, 30 August 2022 P Capital Partners IV B AB (publ) today announces that on 13 September 2022, the company will increase its contributed capital by EUR 43.1 million through the issuance of 196,924 series A1 and 18,200 series A2 participation loan debentures at a price of EUR 96 each and 23,205 series B participation loan debentures at a price of EUR 960 each and by an equity contribution of EUR 0.16 million. The new debentures will be eligible for coupon payments from the third quarter 2022. Including the newly issued debentures, P Capital Partners IV B’s

Temporary production stop at Nordic Paper plant in Greåker will have marginal financial impact

The decided production stop at Nordic Paper plant in Greåker in Norway is planned for three days and is estimated to have marginal financial impact on the results of the company in the third quarter. The production stop is due to the currently very high daily prices for electricity in Norway. The plant is part of the segment Natural Greaseproof and corresponds to about half of the production capacity in the segment. For further information, please contact: Henrik Essén, Head of Investor RelationsPhone: +46 730 573801E-mail: henrik.essen@nordic-paper.com

AFRY enters into a global framework agreement with Elkem

Elkem and AFRY have signed a frame agreement to provide engineering and consulting services for Elkem’s production plants globally. The global frame agreement is a continuation of previous local frame agreements.The frame agreement covers engineering and consulting services such as project management, multi-disciplinary engineering, risk assessments, process optimisation, inspections, digitalisation, construction management and delivery of complete electrical, control and automation systems.  Elkem is one of the world's leading companies within environmentally responsible production of

Patent regarding the new generation of treatment systems approved in Europe

SpectraCure's patent application relating to the technical solution in the new generation of treatment systems has been approved by the European Patent Office.The patent describes the technical solution that allows SpectraCure's treatment system to use the same optical fibers (light guide) to deliver the treatment light and to perform the measurements, to enable individual treatment. The solution of using the same optical fibers for measurement as for treatment, makes SpectraCure unique. "SpectraCure's original basic patent, created by Professor Sune Svanberg, describes this solution. In

Trophy Games Appoints Theis Barenkopf Dinesen as COO

. Press Release    Copenhagen, 30 August, 2022   . Trophy Games has added Theis Barenkopf Dinesen to the executive management. Theis is stepping into the COO-role from a 10 month interim position as Organizational Progress and Collaboration Manager at Trophy Games.  Trophy Games Development’s CEO, Søren Gleie, comments: “We hired Theis last year to streamline the organization and work methods, to additionally be the link between a growing and fast moving organization whilst still keeping an agile work approach and strong company culture. During this time Theis has

Orthex Corporation: Managers’ Transactions – (Ståhlberg)

Orthex Corporation, Managers’ transactions, 30 August 2022 at 11.45 a.m. EEST_______________________________________Person subject to the notification requirementName: Salla StåhlbergPosition: Closely associated personPerson discharging managerial responsibilities in issuerName: Tom StåhlbergPosition: Other senior managerIssuer: Orthex CorporationLEI: 7437008RMK8BSWN39T09Notification type: INITIAL NOTIFICATION____________________________________________ Transaction date: 2022-03-10Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000480504

Repurchase of NCC Series B shares in week 34, 2022

During the period August 22 – August 26, 2022, NCC (LEI-code 213800WRGLW3CY4MHW53) repurchased a total of 220 662 own Series B shares (ISIN: SE0000117970) under the framework of the repurchase program that the Board have decided.The repurchases are part of the repurchase program of a maximum of 10 percent of Series B shares for a total of not more than SEK 1.5 bn that NCC announced on April 27, 2022. The repurchase program extends from May 11, 2022 until the 2023 Annual General Meeting and is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and the

BioStock: Pila Pharma’s CEO comments on the Q2 report

Malmö-based biotech company Pila Pharma advances towards clinical phase II studies with XEN-D0501 at a steady pace. During the second quarter of 2022 the company announced plans to enter a new indication with the drug candidate. BioStock asked the company’s CEO Dorte X. Gram about her views on the second quarter and about the plans ahead.Read the full article at biostock.se: https://www.biostock.se/en/2022/08/pila-pharmas-ceo-comments-on-the-q2-report/This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Smoltek publishes operational update for its Semiconductors business area

This press release is an English version of the previously published Swedish version, which has interpretive precedence. Smoltek Nanotech Holding AB (“Smoltek”) announces that the group company Smoltek Semi AB (“Smoltek Semi”) has made significant progress in the development of the technology for ultra-thin capacitors during the year. The recently announced collaboration agreement with the Yageo Group, one of the world’s largest capacitor manufacturers, is expected to further accelerate the industrialization of Smoltek’s ultra-thin capacitors. This is in line with the goal to be able to

Eurocine Vaccines´ newly added HSV-2 vaccine candidate gains patent protection in South Korea

Eurocine Vaccines has received a Notice of Decision to Grant from the Korean Intellectual Property Office, covering inventions relevant for the newly added vaccine candidate against HSV-2, Herpes Simplex Virus Type 2. Adding South Korea to the territories with granted patents is well in line with the company´s global patent strategy as it is considered one of the four most important pharmaceutical markets in Asia.The received Notice of Decision to Grant not only provides strengthened protection for the technology, but it also validates the level of innovation for the innovation. The patent

Truecaller launches vastly improved iPhone App

Truecaller, the world’s leading global communications platform, has launched a brand-new version of their iPhone app for users around the world. The iOS app has been completely re-written from the ground up to be lighter, more efficient, and most important of all, it offers significantly better number identification, spam-, scam- and business call identification compared to previous versions of the app. The new app offers up to 10 times better spam- and business identification compared to the previous versionThis change has been brought about by an all-new architecture that leverages

Holding(s) in Company

TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00B635TG28 Issuer Name ENQUEST PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Cobas Asset Management, SGIIC, S.A. City of registered office (if applicable) Madrid Country of registered office (if applicable) Spain 4. Details of the shareholder Full name of shareholder(s) if different from the person(s) subject to the notification obligation,

Industrial Solar launches a website with refreshed design and content

Industrial Solar, a 100% subsidiary of Clean Industry Solutions, launched a renewed website with a brand-new look and expanded content. Industrial Solar provides expertise and technology for industrial clients to implement solar energy solutions. The new website reflects Industrial Solar’s holistic approach to solar energy solutions.Industrial Solar’s website has been restored with a fresher and sleeker look in design and more functionality. For instance, visitors can now conduct an in-site search to find more specific information faster. Apart from the usual English and German sites,

Trevian invests alongside Partners Group in large-scale logistics real estate transaction – Trevian will act as asset manager and grow the portfolio further

Trevian acted as the buyer's advisor for the purchase, by private markets investment manager Partners Group, of the SaKa Hallikiinteistöt real estate portfolio in Finland. The portfolio contains 140,000 m2 of real estate in Finland's most central logistics and industrial areas. Trevian will manage the portfolio post acquisition, and the parties aim to grow the portfolio further. Logistics are an attractive and sought-after sector in the real estate investment industry.The SaKa portfolio transaction, which includes a total of 20 properties, is one of the largest in Trevian’s history.

Valtech Unveils Readiness Assessment to Develop Salesforce Composable Commerce Architectures

New Valtech Readiness Assessment is the first solution that helps brands assess the business opportunities and implement the new Salesforce Composable StorefrontValtech , a global business transformation agency, today announced the release of Valtech’s Salesforce Composable Storefront Readiness Assessment, a 30-aspect evaluation, which empowers existing Salesforce Commerce Cloud

Automated planning frees resources at Moelven

In optimizing the production of glued wooden beams, as much material as possible must be glued at the same time. Together with Prevas, Moelven in Töreboda is developing a web-based system that automates the time-consuming planning activities for glue pressing.[En bild som visar person Automatiskt genererad beskrivning] “Our employees are knowledgeable of production,” says Niklas Lindh, production manager at Moelven in Töreboda. “By investing in automation, we can better utilize their skills and experience.” Moelven in Töreboda manufactures glued wooden beams for three customer sectors –

Orthex Corporation: Managers’ Transactions – Sanna Suvanto-Harsaae

Orthex Corporation, Managers’ transactions, 30 August 2022 at 10.30 a.m. EEST_______________________________________Person subject to the notification requirementName: Sanna Suvanto-HarsaaePosition: Chair of the BoardIssuer: Orthex CorporationLEI: 7437008RMK8BSWN39T09Notification type: INITIAL NOTIFICATION_______________________________________Transaction date: 2022-08-29Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000480504Nature of the transaction: ACQUISITIONTransaction details(1): Volume: 232 Unit price: 4.99 EUR(2): Volume: 968 Unit

Dentalum Operations AB (publ) publishes half year report, January -June 2022

Maintained profitability and continued growthSecond quarter, April - June 2022 · Operating revenue increased by 72.8 % to SEK 85.8 million (49.7). · EBITDA amounted to SEK 24.4 million (12.6) · Net earnings amounted to SEK 4.8 million (-0.4). · Operating cash flow amounted to SEK 25.3 million (12.6). Net cash flow totalled SEK – 46.7 million (-64.0). · Total equity amounts to SEK 262.0 million (101.5), cash balance of SEK 198.6 million (110.5) and interest-bearing debt of SEK 397.7 million (300.3). · During the period Dentalum acquired three (3) clinics with annual

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 169 - 30 AUGUST 2022 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 158/22. A/S Motortramp participates in NORDEN’s share buy-back program by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in NORDEN.     Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor

FluoGuide receives permission to start phase IIb trial in aggressive brain cancer

Copenhagen, Denmark, 30 August 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that the company now has received the permission to start the phase IIb clinical trial with FG001.FluoGuide has now received approval from the Danish Ethical Committee and the trial can start in Denmark. FluoGuide announced in April FG001’s highly promising results in aggressive brain cancer (high grade glioma) following its phase I/IIa trial. FG001 was demonstrated to be well tolerated with only few patients reporting mild side effects (3 out of 40 patients). Furthermore, 100% of

Professor Kevin Eva is awarded the Karolinska Institutet Prize for Research in Medical Education

Prof. Kevin Eva is awarded the 2022 Karolinska Institutet Prize for Research in Medical Education (KIPRIME). Prof. Eva is Associate Director and Senior Scientist in the Centre for Health Education Scholarship, and Professor and Director of Educational Research and Scholarship in the Department of Medicine, at the University of British Columbia. He is also Editor-in-Chief of the journal Medical Education. Professor Eva’s work has greatly advanced health professions education research in many key areas and had a profound effect on an entire generation of educators and researchers.Professor

Cysec and Avassa partner up for automated, scalable, and secure edge computing environments

LAUSANNE, SWITZERLAND. and STOCKHOLM, SWEDEN. Cysec, a software provider for confidential computing, and Avassa, an edge application orchestration platform provider, enter a partnership to offer automated, scalable, and secure solutions for edge computing environments.For many enterprises today, it’s no longer a matter of cloud or edge — it’s a matter of both. And with a hybrid infrastructure, businesses need to apply tooling to stay innovative and efficient in both centralized and distributed environments. Cysec, a software provider for confidential computing, and Avassa, an edge

There are no items matching the current filter
There are no more items matching the current filter
Back to top